|Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.|
|PMID: 16087129 Owner: NLM Status: MEDLINE|
|Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of pharmacological agents into clinical practice, thereby denying patients with heart failure (HF) the benefits of drug treatments proven to improve well-being and prolong life. This may be due to unfamiliarity with the evidence-base for these therapies, the clinical guidelines recommending the use of these treatments or both, as well as concerns regarding adverse events. ACE inhibitors have long been the cornerstone of therapy for systolic HF irrespective of aetiology. Recent trials have now shown that treatment with beta-blockers, aldosterone antagonists and angiotensin receptor blockers also leads to substantial improvements in outcome. In order to accelerate the safe uptake of these treatments and to ensure that all eligible patients receive the most appropriate medications, a clear and concise set of clinical recommendations has been prepared by a group of clinicians with practical expertise in the management of HF. The objective of these recommendations is to provide practical guidance for non-specialists, in order to increase the use of evidenced based therapy for HF. These practical recommendations are meant to serve as a supplement to, rather than replacement of, existing HF guidelines.|
|John McMurray; Alain Cohen-Solal; Rainer Dietz; Eric Eichhorn; Leif Erhardt; F D Richard Hobbs; Henry Krum; Aldo Maggioni; Robert S McKelvie; Ileana L Piña; Jordi Soler-Soler; Karl Swedberg|
Related Documents :
|17207719 - Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorb...
9631869 - Indications for ace inhibitors in the early treatment of acute myocardial infarction: s...
15967849 - Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion pol...
20958219 - Short and long term anti-inflammatory effects of bosentan therapy in patients with pulm...
16830089 - A prospective evaluation of nesiritide in the treatment of pediatric heart failure.
3740659 - The case for treatment of selected patients with primary pulmonary hypertension.
21157359 - Thermal suits as an alternative way to keep patients warm peri-operatively: a randomise...
12003419 - Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage ...
20856649 - Stent position is more important than α-blockers or anticholinergics for stent-related...
|Type: Journal Article|
|Title: European journal of heart failure Volume: 7 ISSN: 1388-9842 ISO Abbreviation: Eur. J. Heart Fail. Publication Date: 2005 Aug|
|Created Date: 2005-08-09 Completed Date: 2005-12-13 Revised Date: 2013-05-28|
Medline Journal Info:
|Nlm Unique ID: 100887595 Medline TA: Eur J Heart Fail Country: Netherlands|
|Languages: eng Pagination: 710-21 Citation Subset: IM|
|Department of Cardiology, Western Infirmary, Glasgow, G12 8QQ, UK. firstname.lastname@example.org|
|APA/MLA Format Download EndNote Download BibTex|
administration & dosage,
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors / administration & dosage, therapeutic use*
Benzimidazoles / administration & dosage, therapeutic use
Benzopyrans / administration & dosage, therapeutic use
Bisoprolol / administration & dosage, therapeutic use
Captopril / administration & dosage, therapeutic use
Carbazoles / administration & dosage, therapeutic use
Drug Therapy, Combination
Enalapril / administration & dosage, therapeutic use
Ethanolamines / administration & dosage, therapeutic use
Heart Failure / drug therapy*, physiopathology
Indoles / administration & dosage, therapeutic use
Lisinopril / administration & dosage, therapeutic use
Metoprolol / administration & dosage, analogs & derivatives, therapeutic use
Mineralocorticoid Receptor Antagonists / therapeutic use*
Practice Guidelines as Topic*
Propanolamines / administration & dosage, therapeutic use
Ramipril / administration & dosage, therapeutic use
Spironolactone / therapeutic use
Tetrazoles / administration & dosage, therapeutic use
Valine / administration & dosage, analogs & derivatives, therapeutic use
|0/Adrenergic beta-Antagonists; 0/Angiotensin Receptor Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Benzimidazoles; 0/Benzopyrans; 0/Carbazoles; 0/Ethanolamines; 0/Indoles; 0/Mineralocorticoid Receptor Antagonists; 0/Propanolamines; 0/Tetrazoles; 030Y90569U/nebivolol; 0K47UL67F2/carvedilol; 137862-53-4/valsartan; 37350-58-6/Metoprolol; 52-01-7/Spironolactone; 62571-86-2/Captopril; 66722-44-9/Bisoprolol; 7004-03-7/Valine; 75847-73-3/Enalapril; 83915-83-7/Lisinopril; 87333-19-5/Ramipril; 87679-37-6/trandolapril; S8Q36MD2XX/candesartan; TH25PD4CCB/metoprolol succinate|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surgical left ventricular remodeling in heart failure.
Next Document: Left ventricular SERCA2a gene down-regulation does not parallel ANP gene up-regulation during post-M...